HER2-Positive Breast Cancer | Meet The Professor: Optimizing the Selection and Sequencing of Therapy for Patients with HER2-Positive Breast Cancer — Part 3 of a 6-Part Series - a podcast by Dr Neil Love

from 2021-12-06T17:00

:: ::

Featuring perspectives from Dr Erika Hamilton, including the following topics:

  • Introduction (0:00)
  • Case: A woman in her early 50s with metastatic HER2-positive breast cancer — Nick Leasure, MD (19:02)
  • Case: A woman in her mid-50s with metastatic ER/PR-negative, HER2-positive breast cancer — Estelamari Rodriguez, MD, MPH (22:08)
  • Cases: Three patients with metastatic HER2-positive disease — Kapisthalam (KS) Kumar, MD (24:43)
  • Case: A woman in her early 40s with localized ER/PR-negative, HER2-positive breast cancer — Dr Leasure (31:55)
  • Case: A woman in her late 30s with localized triple-positive breast cancer — Ruth O’Regan, MD (36:34)
  • Case: A woman in her late 40s with localized ER/PR-positive, HER2-positive breast cancer and residual disease — Dr Leasure (40:17)
  • Case: A woman in her early 60s with high-risk, localized ER-positive, HER2-positive breast cancer — Debra Patt, MD, PhD, MBA (44:08)
  • Journal Club with Dr Hamilton (46:00)
  • Beyond the Guidelines (54:06)

CME information and select publications

Further episodes of Research To Practice | Oncology Videos

Further podcasts by Dr Neil Love

Website of Dr Neil Love